SS Innovations International, Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor that recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact, according to a press release from the company. The award reflects the growing adoption of its SSi Mantra surgical robotic system, which the company believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. This widespread adoption underscores the platform's potential to make robotic surgery more accessible globally.
The SSi Mantra system is a key product in SS Innovations' portfolio, which also includes the SSi Mudra surgical instruments. The company, headquartered in India but incorporated in the United States, aims to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The award validates the company's strategy of focusing on affordability and training to drive adoption in emerging markets.
Industry observers note that the surgical robotics market is highly competitive, with established players like Intuitive Surgical dominating. However, SS Innovations' emphasis on cost efficiency and tele-surgery capabilities could differentiate it. The company's achievement of performing 175 telesurgeries is particularly significant, as it demonstrates the ability to deliver surgical expertise remotely, potentially expanding access to care in underserved regions.
The award also reflects SS Innovations' commitment to training: over 2,100 physicians trained on the platform suggests a strong educational component, which is critical for adoption. With regulatory approvals in 14 countries, the company is well-positioned for further expansion. The press release notes that the full announcement can be viewed at https://ibn.fm/XWdRe.
SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. For more information, visit the company's website at ssinnovations.com.
